整合素β1-FAK-Ras-MAPK信号转导通路与肿瘤关系的相关研究进展
阳莲 洪莉
武汉大学人民医院妇产科,湖北武汉 430000
Research progress of the relationship between integrin β1-FAK-Ras-MAPK signal transduction pathway and tumor
YANG Lian HONG Li
Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Hubei Province, Wuhan 430000, China
摘要 整合素β1是整合素家族的主要成员,可以激活多种信号转导途径。FAK-Ras-MAPK信号转导通路是由整合素β1介导的一条重要的信号转导通路,该通路与许多疾病的发生发展密切相关,也是肿瘤发生发展的重要机制之一。这主要与其可以诱导上皮-间质转化、促进肿瘤细胞增殖、抑制肿瘤细胞凋亡、促进肿瘤血管的生成有关,因此该通路也是治疗肿瘤的潜在靶点。本文就整合素β1-FAK-Ras-MAPK信号转导通路的组成、转导机制及其与肿瘤发生发展的相关研究进展予以综述。
关键词 :
整合素&beta ,
1 ,
FAK-Ras-MPKA通路 ,
机制 ,
肿瘤
Abstract :Integrin β1 is the major member of the integrin family, it can activate a variety of signal transduction pathways. The FAK-Ras-MAPK signal transduction pathway is an important signal transduction pathway mediated by integrin β1, which is closely related to the occurrence and development of many diseases, and it is also one of the important mechanisms of tumorigenesis and development. This is mainly related to the fact that it can induce epithelial-mesenchymal transformation, promote the proliferation of tumor cells, inhibit the apoptosis of tumor cells, and promote the formation of tumor blood vessels. Therefore, this pathway has become a potential target for the treatment of tumors. This paper reviews the components, transduction mechanism, and the related research progress on tumorigenesis and development of β1-FAK-Ras-MAPK signal transduction pathway.
Key words :
Integrin β1
FAK-Ras-MPKA pathways
Mechanism
Tumor
基金资助: 国家自然科学基金资助项目(81771562)。
通讯作者:
洪莉(1970-),女,博士,主任医师;研究方向:盆底功能障碍性疾病和妇科肿瘤。
作者简介 : 阳莲(1995-),女,武汉大学人民医院2018级妇产科专业在读硕士研究生;研究方向:盆底功能障碍性疾病和妇科肿瘤。
[1] Gahmberg CG,Gronholm M,Uotila LM. Regulation of integrin activity by phosphorylation [J]. Adv Exp Med Biol,2014,819:85-96.
[2] Skubitz AP. Adhesion molecules [J]. Cancer Treat Res,2002,107:305-329.
[3] Hannigan G,Troussard AA,Dedhar S. Integrin-linked kinase:a cancer therapeutic target unique among its ILK [J]. Nat Rev Cancer,2005,5(1):51-63.
[4] Campbell ID,Humphries MJ. Integrin structure,activation,and interactions [J]. Cold Spring Harb Perspect Biol,2011,3(3):a004994-a004994.
[5] Fang Z,Yao W,Fu Y,et al. Increased integrin alpha5beta1 heterodimer formation and reduced c-Jun expression are involved in integrin beta1 overexpression-mediated cell growth arrest [J]. J Cell Biochem,2010,109(2):383-395.
[6] 杨君伶,姚登福.细胞间黏附分子-1异常表达与肝癌的侵袭生长和转移[J].中华肝脏病杂志,2012,20(2):158-160.
[7] 张宇,桑晨,庄逢源.内皮细胞相关黏附分子的研究进展[J].细胞与分子免疫学杂志,2009,25(1):89-91.
[8] 黎晓,龚妍春.整合素及其信号转导通路的研究进展[J].赣南医学院学报,2007,27(1):153-154.
[9] 潘丽,赵元,秦贵信.整联蛋白β1结构及生物学功能的研究进展[J].中国畜牧杂志,2016,52(3):76-80.
[10] Sun C,Yuan H,Wang L,et al. FAK Promotes Osteoblast Progenitor Cell Proliferation and Differentiation by Enhancing Wnt Signaling [J]. J Bone Miner Res,2016,31(12):2227-2238.
[11] 甄时建,杨举伦.以ras信号通路为靶标的抗肿瘤治疗研究进展[J].临床与实验病理学杂志,2008,24(5):607-612.
[12] 刘婷婷,张淑萍,覃筱燕,等.MAPK信号转导通路与神经损伤研究进展[J].中国公共卫生,2016,32(2):248-254.
[13] 刘红岩.整合素激活FAK介导的信号传导途径研究进展[J].国外医学:免疫学分册,2000(1):3-7.
[14] Cheng SY,Sun G,Schlaepfer DD,et al. Grb2 promotes integrin-induced focal adhesion kinase(FAK) autophosphorylation and directs the phosphorylation of protein tyrosine phosphatase alpha by the Src-FAK kinase complex [J]. Mol Cell Biol,2014,34(3):348-361.
[15] Llinas-Arias P,Esteller M. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer:an update [J]. Open Biol,2017,7(9). pill:170152.
[16] Lamouille S,Xu J,Derynck R. Molecular mechanisms of epithelial-mesenchymal transition [J]. Nat Rev Mol Cell Biol,2014,15(3):178-196.
[17] Naba A,Clauser KR,Lamar JM,et al. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters [J]. Elife,2014,3:e1308.
[18] 孙运良,马建霞,满晓华,等. p38 MAPK信号通路在TLR4促进胰腺癌血管生成中的作用[J].重庆医学,2017, 46(2):161-164.
[19] Wang J,Kuiatse I,Lee AV,et al. Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition,invasion,and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation [J]. Mol Cancer Res,2010,8(2):266-277.
[20] Morris MA,Laverick L,Wei W,et al. The EBV-Encoded Oncoprotein,LMP1,Induces an Epithelial-to-Mesenchymal Transition(EMT)via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling [J]. Cancers(Basel),2018,10(5).
[21] Sheng W,Chen C,Dong M,et al. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway [J]. Cell Death Dis,2017,8(10):e3147.
[22] Jahan R,Macha MA,Rachagani S,et al. Axed MUC4(MUC4/X)aggravates pancreatic malignant phenotype by activating integrin-beta1/FAK/ERK pathway [J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(8):2538-2549.
[23] 卢翠侠.整合素在血管平滑肌细胞增殖和迁移中的作用[J].国际儿科学杂志,2011,38(1):47-50.
[24] 黄坊,谢明,景志亮,等.ERK/MAPK信号通路活性表达与鼻咽癌细胞增殖凋亡的关系[J].中华肿瘤防治杂志,2010,17(15):1192-1195.
[25] Peng X,Wang Z,Liu Y,et al. Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways [J]. Life Sci,2018,206:35-44.
[26] 丁道芳,李玲慧,宋奕,等.MAPK-ERK1/2信号通路调控成骨性基因表达和细胞增殖[J].南方医科大学学报,2013,33(10):1432-1436.
[27] 王文,任玲,王健楠.MAPK信号通路与细胞凋亡的关系[J].中国实用医药,2010,5(15):260-261.
[28] Bao J,Chen X,Hou Y,et al. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway [J]. Biomed Pharma Cother,2018,107:824-833.
[29] Liu P,Liang Y,Jiang L,et al. CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway [J]. Int J Oncol,2018,53(4):1544-1556.
[30] Nisato RE,Hosseini G,Sirrenberg C,et al. Dissecting the role of matrix metalloproteinases(MMP)and integrin alpha(v)beta3 in angiogenesis in vitro:absence of hemopexin C domain bioactivity,but membrane-Type 1-MMP and alpha(v)beta3 are critical [J]. Cancer Res,2005,65(20):9377-9387.
[31] 陈国欢,林群英.整合素与血管生成的关系研究进展[J].医学综述,2015,21(3):420-422.
[32] Liu N,Wu Q,Wang Y,et al. Helicobacter pylori promotes VEGF expression via the p38 MAPKmediated COX2PGE2 pathway in MKN45 cells [J]. Mol Med Rep,2014,10(4):2123-2129.
[33] 韩超,许利剑.整合素在上皮间质转化中的作用机制[J].医学研究生学报,2015,28(7):780-784.
[1]
张艳 吴晨光. miR-200c在甲状腺癌中的研究进展 [J]. 中国医药导报, 2019, 16(9): 56-58,63.
[2]
周京元 索南昂秀. 桥接组合式内固定系统治疗肱骨干下1/4骨折不愈合患者的临床效果 [J]. 中国医药导报, 2019, 16(9): 75-78.
[3]
赵君雅 李威 李薇 孙鸿宇 李欣 官杰▲. 溃疡性结肠炎大鼠肠黏膜中IL-35与IL-17的表达及意义 [J]. 中国医药导报, 2019, 16(9): 15-18.
[4]
刘远识 徐细明 陈心 伍龙. 长链非编码RNA-LET在肿瘤中的研究进展 [J]. 中国医药导报, 2019, 16(9): 26-29,42.
[5]
姜彤伟1 郝珍珠2 王冰梅3 郭慧文2 朴星虎2 程祺2. 心肌缺血再灌注损伤中西医机制及相关药物治疗的研究进展 [J]. 中国医药导报, 2019, 16(9): 43-46,51.
[6]
张洁1 金华1 古丽米热·布然江1 李小文1 姚丽艳2. 宫颈癌组织中缺氧诱导因子-1α、葡萄糖转运蛋白1的表达及临床意义 [J]. 中国医药导报, 2019, 16(9): 86-89.
[7]
闫配1 张晓红1▲ 张莉1 李瑾2. HMW-ADP、TNF-α、VEGF与糖尿病视网膜病变的关系研究 [J]. 中国医药导报, 2019, 16(9): 106-109.
[8]
谭锦辉 李博 黄海 佘若男 吴系美. 风湿清合剂联合甲氨蝶呤治疗活动期类风湿关节炎的效果 [J]. 中国医药导报, 2019, 16(9): 158-161.
[9]
洪汉青1 张彩荣2 陈德春3 花志娟3 王佩1 阮志忠2. 针刀治疗膝骨性关节炎的临床效果 [J]. 中国医药导报, 2019, 16(9): 162-165,169.
[10]
李红霞 孟宪宁▲ 霍志平 吴亚男 王宏利 郝媛媛. 卵巢子宫内膜异位症患者BDNF、CA125水平检测及其诊断价值分析 [J]. 中国医药导报, 2019, 16(8): 80-83.
[11]
全立元 李明丽 夏明月 冯悦 黄伟 刘灵. 秦皇岛地区1型糖尿病儿童及青少年生存质量影响因素研究 [J]. 中国医药导报, 2019, 16(8): 140-142,147.
[12]
王露1 白桦1 韩梅1 赵玉岩2. 2型糖尿病患者血清脂肪细胞型脂肪酸结合蛋白、白细胞介素-17水平及其与下肢动脉粥样硬化病变的关系 [J]. 中国医药导报, 2019, 16(8): 116-119,135.
[13]
汪白云1 杨柳2 刘国良2 朴成玉3 李庆伟2 薛慧2 刘斌2. 基于代谢网络技术的补阳还五汤对APP/PS1双转基因小鼠干预作用的研究 [J]. 中国医药导报, 2019, 16(8): 13-17.
[14]
何晓焱1 彭诗寒1 赵磊1 罗玉萍1 刘霞2. 血浆miRNA-126表达与妊娠期高血压疾病的相关性分析 [J]. 中国医药导报, 2019, 16(8): 76-79.
[15]
周晓 程志祥. BET家族及其抑制剂在肿瘤中的研究进展 [J]. 中国医药导报, 2019, 16(8): 26-29,46.